Literature DB >> 31915420

Surgical Options and Approaches for Lower Gastrointestinal Bleeding: When do we operate and what do we do?

Laura Greco1, Jeanette Zhang1, Howard Ross1.   

Abstract

Lower gastrointestinal bleeding (LGIB) is a common entity encountered by the surgeon. Though most LGIB stops on its own, familiarity with the diagnoses and their treatments is critical to optimal patient care. Even in 2016, surgery may be required. Advances in imaging have led to an enhanced ability to localize bleeding. Newer anticoagulants have developed which provide ease of use to the patient, but challenges to caregivers when bleeding arises. © Thieme Medical Publishers.

Entities:  

Keywords:  CT angiography; angioembolization; anticoagulation; lower gastrointestinal hemorrhage; surgery

Year:  2020        PMID： 31915420      PMCID： PMC6946603          DOI： 10.1055/s-0039-1693439

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN： 1530-9681


  25 in total

Review 1.  Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies.

Authors:  Jay Desai; Jennifer M Kolb; Jeffrey I Weitz; James Aisenberg
Journal:  Thromb Haemost       Date:  2013-05-23       Impact factor: 5.249

Review 2.  Management of ectopic varices.

Authors:  I D Norton; J C Andrews; P S Kamath
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

3.  Arteriography for Lower Gastrointestinal Hemorrhage: Role of Preceding Abdominal Computed Tomographic Angiogram in Diagnosis and Localization.

Authors:  Christina L Jacovides; Gregory Nadolski; Steven R Allen; Niels D Martin; Daniel N Holena; Patrick M Reilly; Scott Trerotola; Benjamin M Braslow; Lewis J Kaplan; Jose L Pascual
Journal:  JAMA Surg       Date:  2015-07       Impact factor: 14.766

4.  Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Authors:  John W Eikelboom; Lars Wallentin; Stuart J Connolly; Mike Ezekowitz; Jeff S Healey; Jonas Oldgren; Sean Yang; Marco Alings; Scott Kaatz; Stefan H Hohnloser; Hans-Christoph Diener; Maria Grazia Franzosi; Kurt Huber; Paul Reilly; Jeanne Varrone; Salim Yusuf
Journal:  Circulation       Date:  2011-05-16       Impact factor: 29.690

5.  Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

Authors:  Shaun G Goodman; Daniel M Wojdyla; Jonathan P Piccini; Harvey D White; John F Paolini; Christopher C Nessel; Scott D Berkowitz; Kenneth W Mahaffey; Manesh R Patel; Matthew W Sherwood; Richard C Becker; Jonathan L Halperin; Werner Hacke; Daniel E Singer; Graeme J Hankey; Gunter Breithardt; Keith A A Fox; Robert M Califf
Journal:  J Am Coll Cardiol       Date:  2013-12-04       Impact factor: 24.094

6.  Perioperative management of patients on new oral anticoagulants.

Authors:  A Lai; N Davidson; S W Galloway; J Thachil
Journal:  Br J Surg       Date:  2014-04-29       Impact factor: 6.939

7.  Abdominal colectomy offers safe management for massive lower GI bleed.

Authors:  R Baker; A Senagore
Journal:  Am Surg       Date:  1994-08       Impact factor: 0.688

8.  Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts.

Authors:  N Kochar; D Tripathi; N C McAvoy; H Ireland; D N Redhead; P C Hayes
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

Review 9.  Non-Vitamin K Antagonist Oral Anticoagulants: The Clinician's New Challenge.

Authors:  Brian K Yorkgitis; Jeanette Zhang; Joseph F Rappold
Journal:  J Am Osteopath Assoc       Date:  2015-10

10.  Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.

Authors:  Deborah M Siegal; John T Curnutte; Stuart J Connolly; Genmin Lu; Pamela B Conley; Brian L Wiens; Vandana S Mathur; Janice Castillo; Michele D Bronson; Janet M Leeds; Florie A Mar; Alex Gold; Mark A Crowther
Journal:  N Engl J Med       Date:  2015-11-11       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.